FDA Inspection 1053347 — Pacific Cancer Institute, Inc.
The FDA completed an inspection of Pacific Cancer Institute, Inc. on May 1, 2018 in Wailuku, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 1, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wailuku, HI (United States)